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Histone mRNAs are rapidly degraded at the end of S phase, and a 26-nucleotide stem-loop in the 3= untranslated region is a key
determinant of histone mRNA stability. This sequence is the binding site for stem-loop binding protein (SLBP), which helps to
recruit components of the RNA degradation machinery to the histone mRNA 3= end. SLBP is the only protein whose expression
is cell cycle regulated during S phase and whose degradation is temporally correlated with histone mRNA degradation. Here we
report that chemical inhibition of the prolyl isomerase Pin1 or downregulation of Pin1 by small interfering RNA (siRNA) in-
creases the mRNA stability of all five core histone mRNAs and the stability of SLBP. Pin1 regulates SLBP polyubiquitination via
the Ser20/Ser23 phosphodegron in the N terminus. siRNA knockdown of Pin1 results in accumulation of SLBP in the nucleus.
We show that Pin1 can act along with protein phosphatase 2A (PP2A) in vitro to dephosphorylate a phosphothreonine in a con-
served TPNK sequence in the SLBP RNA binding domain, thereby dissociating SLBP from the histone mRNA hairpin. Our data
suggest that Pin1 and PP2A act to coordinate the degradation of SLBP by the ubiquitin proteasome system and the exosome-
mediated degradation of the histone mRNA by regulating complex dissociation.
The prolyl isomerase Pin1 has diverse effects on cellular metab-olism that include control of the cell cycle, regulation of cell
differentiation, proliferation, and genomic stability (11, 36, 38,
64). Pin1 catalyzes cis-trans prolyl isomerization in its substrates,
facilitating conformational changes that regulate protein func-
tion. Proteins identified as Pin1 targets include mitotic phospho-
proteins (4, 17, 60), transcription factors (14, 34, 49), and cell
cycle regulators (46, 63). Pin1 is specific for phosphorylated Ser/
Thr-Pro sequences and acts along with kinases and phosphatases
to exert its biochemical effects.
Pin1 plays an essential role in regulating transcription initia-
tion, elongation, and termination (61, 62). In both yeast and
mammals, Pin1 (Ess1 in yeast) regulates the conformation and
phosphorylation state of the RNA polymerase (RNAP) II carboxy-
terminal domain (CTD) (1, 41). Ess1 promotes dephosphoryla-
tion of Ser-5 of the heptad repeat (Y-S2-P-T-S5-P-S) in the CTD
by interactions with CTD-associated phosphatases Ssu72 and
Pcf11, thereby regulating the association of the CTD with compo-
nents of the 3=-end processing machinery (24, 56). Yeast Ess1 is
required for transcription termination of small noncoding RNAs
such as snoRNAs, cryptic unstable transcripts (CUTs), and up-
stream regulatory RNAs (uRNAs) via the Nrd1 pathway (51). Ess1
functionally interacts with the transcription initiation factor
TFIIB, Ssu72 phosphatase, and Pta1 components of the 3=-end
processing machinery to influence gene looping (24). Besides its
effects on transcription, Pin1 has been implicated in the control of
mRNA stability of three AU-rich element (ARE)-containing
mRNAs, namely, those for granulocye-macrophage colony-stim-
ulating factor (GM-CSF), parathyroid hormone (Pth), and trans-
forming growth factor  (TGF-), in the cytoplasm (10, 25).
These effects are mediated via direct association of Pin1 with
phosphorylated forms of the ARE-binding proteins AUF1 and
KSRP. Pin1 promotes dephosphorylation of AUF1 and KSRP in
vivo, regulating their interactions with the ARE sequences in the 3=
untranslated regions (UTRs) of the respective mRNAs.
Histone mRNAs are a unique set of eukaryotic transcripts that
accumulate primarily during S phase (40). They are the only eu-
karyotic cellular mRNAs that are not polyadenylated, ending in-
stead in a conserved stem-loop. These mRNAs have very short
half-lives, approximately 40 min and 10 min during and at the end
of S phase, respectively (2, 15). Stem-loop binding protein (SLBP)
is a histone mRNA-specific processing factor that binds the stem-
loop at the 3= end of histone mRNA. The SLBP-histone mRNA
complex functions as a coordinate unit in all steps of histone
mRNA metabolism. SLBP is the only protein involved in histone
mRNA metabolism whose expression during S phase is tempo-
rally correlated to that of histone mRNAs.
In this study, we use an integrated nuclear magnetic resonance
(NMR), biochemical, and biological approach to show that the
prolyl isomerase activity of Pin1 regulates the SLBP-histone
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mRNA complex. We have recently shown that SLBP undergoes
proline isomerization about a conserved phosphorylated Thr-Pro
sequence in its RNA binding domain (RBD) (3, 29, 65). There are
six Ser-Pro/Thr-Pro sequences in human SLBP, all of which have
been previously shown to be phosphorylated by mass spectrome-
try (12). We confirmed the existence of these additional phos-
phorylation sites by mass spectrometry and show that multisite
phosphorylation at the N terminus at either Ser7, Ser20, Ser23,
Thr60, or Thr61 in addition to Thr171 in the RNA binding do-
main is required for efficient interaction of SLBP with Pin1. We
also mapped the binding site on Pin1 for SLBP by NMR spectro-
scopy and confirmed that Pin1 interacts with a conserved phos-
pho-Thr171-Pro172 sequence in the SLBP RBD. We show that
Pin1 and protein phosphatase 2A (PP2A) play an important role
in dissociating SLBP from the histone mRNA 3= end. Moreover,
when Pin1 was downregulated by small interfering RNA (siRNA)
or the prolyl isomerase activity of Pin1 was inhibited, we observed
an increase in SLBP stability, increased accumulation of polyubiq-
uitinated SLBP, and an increase in the abundance of histone
mRNAs that was directly attributed to decreased rates of mRNA
decay.
Our results suggest that at the end of S phase, SLBP is likely
dephosphorylated at T171 by Pin1 and PP2A to trigger dissocia-
tion of SLBP from the histone mRNA. This facilitates histone
mRNA decay in the cytoplasm, and the free SLBP likely relocalizes
to the nucleus, facilitating SLBP ubiquitination and degradation.
Therefore, Pin1 and PP2A work to intersect two major pathways
of gene expression at the end of S phase, namely, the degradation
of SLBP by the ubiquitin proteasome system and the exosome-
mediated degradation of the histone mRNA by regulating com-
plex dissociation.
MATERIALS AND METHODS
Protein and RNA constructs. Full-length and SLBP RNA binding and
processing domains (RPDs) were subcloned into the NcoI and XhoI re-
striction sites of the baculovirus vector pFastBacHTA and were expressed
using the Bac-to-Bac expression system (Invitrogen) previously described
(7). Sf21 cells were infected with baculovirus (at a density of 5  105
cells/ml) in serum-free SF900 medium (Gibco) and purified using stan-
dard protocols using nickel affinity chromatography. Phosphorylation of
all proteins was confirmed by high-resolution tandem mass spectrometry
at the Keck MS and Proteomics Resource at Yale University (T. T. Lam
and R. Thapar, unpublished data). The samples were concentrated and
buffer exchanged using a G25 column into NMR buffer or phosphate-
buffered saline (PBS) for the dissociation assays. Human Pin1 was ex-
pressed as a glutathione S-transferase (GST) fusion protein and purified
by glutathione (GSH) affinity chromatography using a HiTrap GST col-
umn (GE) for the NMR chemical shift mapping experiments. The GST
was cleaved with biotinylated thrombin, and the residual thrombin was
removed using streptavidin beads. The cleaved and uncleaved proteins
were separated by putting the mixture over a second glutathione (GSH)-
bead column. The protein was further cleaned up on an S200 Superdex
column (GE). Uniformly 15N-labeled Pin1 was made by growing bacteria
in minimal medium with 15NH4Cl as the sole source of nitrogen and
purified as described above. Pin1 was expressed from the vector pET28a
for the dissociation experiments and was purified using nickel affinity and
gel filtration chromatographies. Threonine-phosphorylated and unphos-
phorylated peptides corresponding to residues His161-Arg180 (161HLRQ
PGIHPKTPNKFKKYSR180) of human SLBP were synthesized by Sigma-
Genosys. The SFTpTP peptide (made at the UNC peptide core facility) has
a single phosphate on Thr61 and corresponds to residues 54 to 68 (54RR
PESFTTPEGPKPR68) from the N terminus of human SLBP (hSLBP). All
peptides were at least 90% pure as determined by reverse-phase high-
performance liquid chromatography (HPLC) and matrix-assisted laser
desorption ionization–mass spectrometry (MALDI-MS). The stem-loop
RNAs, labeled with fluorescein at either the 5= or 3= end, were synthesized
by Dharmacon, Inc. The RNA was folded by heating at 95°C for 2 min and
snap-cooled on ice for 10 min to ensure the lowest-energy hairpin con-
former.
Antibodies and reagents. Rabbit polyclonal anti-Pin1, mouse monoclo-
nal antihemagglutinin (anti-HA), and goat anti-SC-35 antibodies were ob-
tained from Santa Cruz; an in-house rabbit polyclonal anti-SLBP antibody
made toward the C terminus of human SLBP was used for the Western blots;
and goat polyclonal anti-SLBP (Santa Cruz Antibodies) was used in the
ImageStream (IS) flow cytometry experiments. For immunofluorescence ex-
periments, a rabbit monoclonal antibody toward Pin1 (Abcam) was used and
a mouse monoclonal antibody toward HA (Abcam) was used. Antibodies
toward the following proteins were purchased from Bethyl Laboratories: eu-
karyotic initiation factor 4G1 (eIF4G1), eIF4E, CPSF73, CPSF100, CPSF160,
CPSF30, actin, symplekin, CSTF64, and Myc. Rabbit polyclonal antibody for
histone H3 was purchased from Abcam. Anti-Flag biotinylated M2 monoclo-
nal antibody was purchased from Sigma. Purified PP2A and PP1 protein
Ser/Thr phosphatases were obtained from Biomol and NEB, respectively. The
Pin1 inhibitor PiB (diethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzol-phe-
nanthroline-2,7-diacetate) was purchased from Sigma and resuspended in
dimethyl sulfoxide (DMSO). The proteasome inhibitor N-acetyl-Leu-Leu-
Nle-CHO (ALLN) was purchased from Calbiochem.
Pin1 RNA interference (RNAi). HeLa cells were cultured in Dulbec-
co’s modified Eagle medium (DMEM) with 10% fetal bovine serum. Pin1
siRNA and control C2 RNAs were obtained from Dharmacon’s ON-
TARGETplus siRNA collection (catalog number 003291), and the knock-
down was performed using Lipofectamine RNAiMax (Invitrogen) using a
two-hit method (55). We used either a single siRNA corresponding to the
sequence 5=-GCUCAGGCCGAGUGUACUAA-3= or a pool of four differ-
ent siRNAs from the ON-TARGETplus SMARTpool siRNA collection
(the sequences are 5=-CCACAUCACUAACGCCAGC-3=, 5=-GAAGAUC
ACCCGGACCAAG-3=, 5=-GAAGACGCCUCGUUUGCGC-3=, and 5=-G
CUCAGGCCGAGUGUACUA-3=). Similar effects were observed irre-
spective of whether a single siRNA or the pool of four different siRNAs
was used, indicating that the off-target effects were minimal. The second
siRNA transfection was performed 48 h after the first hit, and the cells
were cultured for another 72 h before harvesting for microarray analysis
or reverse transcription-PCR (RT-PCR).
Isolation of total RNA for RT-PCR. HeLa cells were lysed in 1 ml of
TRIzol reagent (Invitrogen). The homogenized sample was incubated for
5 min at room temperature to permit complete dissociation of nucleopro-
tein complexes. Two hundred microliters of chloroform was added per 1
ml of TRIzol reagent, mixed vigorously, and allowed to sit at room tem-
perature for 2 to 3 min. The samples were centrifuged at 12,000  g for 15
min at 4°C. Centrifugation separated the biphasic mixtures into the lower
red phenol-chloroform phase and the upper colorless aqueous phase.
RNA was precipitated from the upper aqueous phase using 1 ml of iso-
propanol. The samples were centrifuged at 12,000  g for 10 min at 4°C.
The RNA pellet was washed once with 2 ml of 75% ethanol, air dried, and
redissolved in 25 l of diethyl pyrocarbonate (DEPC)-treated water. Total
RNA obtained was purified using PureLink Micro-to-Midi RNA purifi-
cation system (Invitrogen) as per the manufacturer’s instructions. All
RNA samples used for RT-PCR had a ratio of optical densities (OD) at 260
and 280 nm of 1.9 to 2.0 (NanoDrop).
Quantitative RT-PCR. Real-time quantitative reverse transcription-
PCR (qRT-PCR) was performed using a Bio-Rad MyiQ single-color real-
time PCR system. The cDNAs were synthesized from 1.5 g of total RNA
using SuperScript III reverse transcriptase (200 U/l) (Invitrogen) with
random hexamers as per the manufacturer’s instructions. The primers
were designed using the program Primer3 (http://frodo.wi.mit.edu
/primer3/) and are summarized in Table S1 in the supplemental material.
The real-time PCR primers were synthesized by Integrated DNA Technol-
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ogies (IDT), Coralville, IA (see Table S1 in the supplemental material).
The reaction components were added as follows to the indicated final
concentrations: 2.5 l of water, 4.5 l of forward primer (5 M), 4.5 l of
reverse primer (5 M) 12.5 l of SYBR green (Applied Biosystems), and 1
l of cDNA. The cycling profile for each run was 50°C for 2 min, 95°C for
10 min, and 40 cycles of 95°C for 15 s, followed by 60°C for 10 min, using
the default ramp rate. The change in gene expression levels was deter-
mined by normalizing mRNA levels of the gene of interest to the mRNA
level of the housekeeping gene, the glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) gene, using the comparative threshold cycle (CT)
method. Several controls were also performed to determine whether the
change in histone mRNA levels in response to Pin1 siRNA treatment
could be rescued. Control and siRNA-treated HEK293 cells were tran-
siently transfected with wild-type Pin1 (Pin1 WT), the Pin1 W34A mu-
tant, SLBP WT, or the SLBP T171A or SLBP T171E mutant 48 h after the
second hit for an additional 24 h. The total mRNA levels were determined
as described above.
FACS and IS flow cytometry. HeLa cells were collected and washed in
cold PBS, resuspended in PBS, and fixed in chilled ethanol overnight. Cells
were then washed and resuspended in PBS with propidium iodide (PI) for
30 min at 37°C. DNA content was measured by flow cytometry (fluores-
cence-activated cell sorting [FACS]) and analyzed in Modfit. IS flow cy-
tometry was performed using IS100 (Amnis) on HeLa cells that were
stained for anti-SLBP fluorescein isothiocyanate (FITC) and DRAQ5 for
nuclear imaging. A total of 5,000 events were collected for both control
and Pin1 siRNA-treated cells. The cell populations were gated for single
cells that were in focus and were positive for both DRAQ5 and anti-SLBP
FITC. The spatial relationship between SLBP and DRAQ5 was measured
using the “Similarity” feature in the IDEAS software package. The simi-
larity score (SS) is a log-transformed Pearson’s correlation coefficient be-
tween the pixel values of two image pairs, which provides a measure of the
degree of nuclear localization of SLBP by measuring the pixel intensity
correlation between the SLBP and DRAQ5 (nuclear dye) images. Cells
with low SSs exhibit no correlation between the images, whereas cells with
high SSs exhibit a positive correlation between the images.
Coimmunoprecipitation and Western blot analysis. HeLa cells were
cultured in DMEM with 10% fetal bovine serum. HeLa cell extract was
prepared from 1  107 cells. Cells were lysed in NP-40 lysis buffer and
spun at 13,000  g for 10 min at 4°C. The lysate was probed for the protein
under investigation by Western blotting with enhanced chemilumines-
cence (ECL). For the coimmunoprecipitation studies, HeLa cells stably
expressing HA-SLBP were cultured in DMEM with 10% fetal bovine se-
rum. Total cell extract was prepared from 1  107 cells. Cells were lysed,
and the lysate was precleared and then incubated either with an anti-Pin1
antibody or anti-Myc (as a control), 50 l of protein A/G Plus beads
(Santa Cruz Antibodies), and 10 g/ml RNase A where indicated, over-
night at 4°C. The next day, the beads were washed five times with lysis
buffer with end-over mixing for 1 min, followed by spinning of the beads
at 3,000  g for 1 min at 4°C for each wash. The bound proteins were
resolved on a 15% SDS-PAGE gel and probed for Pin1 or the HA tag by
Western blotting with ECL. For coimmunoprecipitation of Pin1 with
SLBP mutants, Flag-tagged SLBP wild-type and SLBP T60A/T61A,
T171A, T60A/T61A/T171A, S7A, S20A/S23A, and S20A/S23A/T171A
mutants were cloned into vector pcDNA3.1 and transiently transfected
into HeLa cells. Cells were harvested after 48 h. The cells were immuno-
precipitated using anti-Flag M2 affinity resin (Sigma) as described above
and probed for Pin1 and Flag-tagged SLBP by Western blotting.
For coimmunoprecipitation of translation initiation factors with
SLBP, HEK293 cells were treated with control or Pin1 siRNAs and the cells
harvested. The cells were lysed as described above and immunoprecipi-
tated with SLBP antibody toward the C-terminal 13 amino acids of hu-
man SLBP and probed for SLBP, eIF4G, and eIF4E by Western blotting.
Analysis of histone mRNA decay rates. HEK293 cells were synchro-
nized by double thymidine block, released into S phase, and either mock
treated with DMSO or treated with 20 M PiB for a total of 16 h before
being harvested. Actinomycin D was added to block transcription to a
final concentration of 5 g/ml to cells 6 h prior to harvesting. HEK293
cells (1  106) were harvested at different time points (0, 0.25, 0.5, 0.75, 1,
and 1.25 h) after the addition of 5 mM hydroxyurea (HU) to trigger
histone mRNA decay for analysis of mRNA levels. mRNA abundance was
quantified using RT-PCR.
SLBP stability assay. HEK293 cells were mock treated with DMSO or
treated with 20 M PiB for 16 h. The levels of SLBP were analyzed at
different time points (1, 2, 4, 6, and 8 h) after treatment with 50 g/ml of
cycloheximide (CHX) in the presence or absence of PiB.
Ubiquitination assays. HEK293 cells were transiently transfected
with HA-ubiquitin and the Flag-tagged SLBP constructs with Lipo-
fectamine 2000 (Invitrogen). Twenty-four hours later, the cells were
treated with 20 M PiB for 16 h or mock treated with DMSO as indicated
below. The cells were treated with ALLN to inhibit the proteasome to a
final concentration of 40 M for 4 h prior to being harvested. After lysis
with RIPA buffer (1% Nonidet P-40, 0.5% Triton X-100, 0.1% SDS, 50
mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.5 mM EDTA, 25 M ALLN, and
protease inhibitors), protein extracts were incubated with anti-Flag beads
(Sigma), washed five times, resolved by SDS-PAGE, and analyzed by
Western blotting. In an alternative approach, Pin1 was knocked down by
siRNA in HEK293 cells, and 48 h after the second hit, the cells were tran-
siently transfected with (His)6-ubiquitin and the Flag-tagged SLBP con-
structs. Twenty-four hours after transient transfection, the cells were
blocked with ALLN. The control and siRNA-treated cells were lysed in 6
M guanidine HCl in PBS buffer (pH 8.5). The lysates were incubated with
nickel affinity resin (Qiagen) with gentle agitation for 6 h to bind ubiq-
uitinated proteins. The beads were washed sequentially with 6 M guani-
dine HCl at pH 8.5, 6 M guanidine HCl at pH 6.0, 6 M guanidine HCl at
pH 7.0 with 10 mM imidazole, 6 M guanidine HCl at pH 7.0, 0.2% NP-40,
and 20% glycerol in PBS. The bound proteins were eluted with 100 mM
imidazole in PBS and were analyzed by Western blotting for SLBP and
ubiquitin.
Mass spectrometry. (i) Sample preparation. HEK293 cells were tran-
siently transfected with Flag-tagged wild-type SLBP using Lipofectamine
2000 for 24 h and then either mock treated with DMSO or treated with 20
M PiB for 16 h. The cells were lysed and the lysates bound to anti-Flag
M2 affinity gel (Sigma) by nutation with the beads for 12 h. The resin was
washed three times with lysis buffer. Flag-tagged SLBP bound to the beads
was eluted with 3 Flag peptide (Sigma). The control and PiB-treated
eluates were dialyzed extensively in 0.1% acetic acid. For in-solution pro-
tein digestion, the samples were dried and dissolved in 8 M urea and 0.4 M
ammonium bicarbonate (pH 8.0). The proteins were reduced by the ad-
dition of dithiothreitol (DTT) and then alkylated with iodoacetamide
(IAN) by incubation in the dark for 20 min. Samples were then digested
with trypsin at a 1:10 molar ratio of trypsin to SLBP by incubation at 37°C
for 16 h.
For preparation for the liquid chromatography-tandom mass spec-
trometry (LC MS-MS) analysis, the phosphopeptides present in the tryp-
tic digests were enriched using an in-house titanium oxide enrichment
method. Briefly, the samples were acidified with 0.5% trifluoroacetic acid
(TFA)–50% acetonitrile and loaded onto TopTips (Glygen Corp.), fol-
lowed by washing three times with 100% acetonitrile, 0.2 M sodium phos-
phate buffer (pH 7.0), 0.5% TFA, and then 50% acetonitrile. Phospho-
peptides were eluted from the TopTip using 28% ammonium hydroxide,
dried in a SpeedVac, and then redried from water. Samples were resus-
pended in 70% formic acid and then immediately diluted out to 0.1% TFA
for mass spectrometry analysis. The flowthrough from the washes and the
enriched fractions were analyzed by LC MS-MS.
(ii) Data analysis and processing. Samples were analyzed
by LC MS-MS using an LTQ Orbitrap Elite equipped with a Waters
nanoAcquity ultraperformance liquid chromatography (UPLC) system
using a Waters Symmetry C18 180-m by 20-mm trap column and a
1.7-m (75-m-inner-diameter by 250-mm) nanoAcquity UPLC col-
umn (35°C) for peptide separation. Trapping was done at 15 l/min with
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99% buffer A (100% water, 0.1% formic acid) for 1 min. Peptide separa-
tion was performed at 300 nl/min with buffer A and buffer B (100%
CH3CN containing 0.1% formic acid). A linear gradient (51 min) was run
with 5% buffer B at initial conditions, 50% buffer B at 50 min, and 85%
buffer B at 51 min. Mass spectral data were acquired in the Orbitrap using
1 microscan and a maximum inject time of 900 s followed by data-
dependent MS-MS acquisitions in the ion trap (via collision-induced dis-
sociation [CID]) and in the high-energy collision dissociation (HCD) cell.
Neutral loss scans (MS3) were also obtained for 98.0, 49.0, and 32.7 atomic
mass units (amu). The data were searched using Mascot Distiller and the
Mascot search algorithm. The data were processed with Progenesis LCMS
(Nonlinear Dynamics, LLC), and protein identification was performed
using the Mascot search algorithm (Matrix Science).
For quantification of the relative enrichment of phosphopeptides, the
control run was chosen as a reference, and the experimental run (PiB)
was chromatographically aligned to that run in order to minimize reten-
tion time variability between the two runs. No adjustments are necessary
in the m/z dimension due to the high mass accuracy of the spectrometer
(typically 3 ppm). Peak detection was set with default parameters (stan-
dard deviation of signal/noise of 3). A total of 5,000 features were de-
tected within retention time ranges of 16 to 100 min, for peptides having
7 or fewer charges on them. A normalization factor (a global scaling
factor) was calculated for each run to account for differences in sample
loading between injections and minimum influence of noise in the data.
The features (picked peaks) and their corresponding data-dependent
MS-MS data were filtered to exclude spectra with a rank of 10 (only the
top 10 MS-MS acquisitions per feature were included) or isotope of 3 to
ensure that the highest-quality MS-MS spectral data were utilized for
peptide assignments and subsequent protein identification (ID). The
MS-MS data were exported to an .mgf (Mascot generic file) for database
searching utilizing an in-house Mascot algorithm (version 2.2.0) (16) for
uninterpreted MS-MS spectra after using the Mascot Distiller program to
generate Mascot-compatible files. The Mascot Distiller program com-
bines sequential MS-MS scans from profile data that have the same pre-
cursor ion. The Mascot search parameters utilized were partial methio-
nine oxidation and carboxamidomethylated cysteine, a peptide tolerance
of 15 ppm, MS-MS fragment tolerance of 0.6 Da, peptide charges of
7 or fewer, and missed cleavages of 3 or fewer. Normal and decoy Swiss-
Prot protein database searches were run, with GluC and trypsin as the
enzymes used. The Mascot significance score match is based on a MOWSE
(molecular weight search) score and relied on multiple matches to more
than one peptide from the same protein. After the Mascot search, an .xml
file of the results is created and then imported into the Progenesis LCMS
software, where search hits are paired with the LCMS quantitation on the
peptide mass.
Electrophoretic mobility shift assays (EMSA). Baculovirus-ex-
pressed human SLBP was incubated with a stem-loop probe labeled at the
5= end with 	-32P for 10 to 20 min on ice in binding buffer (20 mM Tris
[pH 7.9], 20% glycerol, 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.1
mg/ml bovine serum albumin [BSA]). This preformed end-labeled stem-
loop SLBP complex was then treated with Pin1 in either the presence or
absence of the phosphatases PP2A and PP1. A 10-fold molar excess of cold
competitor RNA was added to reaction mixtures after the preincubation
period as specified below. All reaction mixtures were kept on ice for 5 min,
after which they were run on a native gel to monitor dissociation of the
complex. The total reaction volume (10 l) was analyzed on an 8% native
polyacrylamide Tris-borate gel run in Tris-borate buffer at 150 V for 1 to
1.5 h. The gel was dried at 80°C for 2 h and then exposed to film. All
reactions were repeated 5 times, and the observed dissociation of the
SLBP-RNA complex was reproducible with different stocks of human
full-length SLBP and Drosophila full-length SLBP as well as the RBDs. The
relative ratios of SLBP to Pin1 used are indicated in the figures and figure
legends.
Fluorescence measurements to monitor Pin1-mediated dissocia-
tion of the SLBP-histone mRNA stem-loop complex. Fluorescence an-
isotropy measurements were performed with a Jobin-Yvon Horiba Fluo-
romax spectrofluorometer with a 26-nucleotide histone mRNA that was
3=end labeled with fluorescein in phosphate buffer. Unlabeled stem-loop
RNA was used in the competition experiments. Proteins were titrated (as
specified below) into a 0.5-cm quartz cuvette that contained the fluores-
cently labeled RNA solution, and the anisotropy was measured (
excitation 
492 nm; 
emission  518 nm) at 25°C. The data were fit in GraphPad Prism
to the appropriate binding equations.
Fluorescence microscopy. HeLa cells grown on coverslips were
washed with PBS and fixed in 4% formaldehyde in PBS for 15 min at room
temperature. Cells were washed again and permeabilized in 0.5% Triton
X-100 in PBS for 20 min. The cells were blocked with Image-iT FX signal
enhancer (Invitrogen) for 30 min. The blocking solution was removed
and the cells were washed once in PBS. Cells were incubated overnight
with anti-HA antibody in 3% BSA– 0.1% Triton X-100 in PBS. Coverslips
were washed three times for 10 min each with 0.1% Triton X-100 in PBS.
The cells were then incubated with Alexa Fluor 647 goat anti-mouse sec-
ondary antibody (Invitrogen) in 0.1% Triton X-100 in PBS for 1 h. Cov-
erslips were 4=,6-diamidino-2-phenylindole (DAPI) stained and washed
three times for 10 min each with 0.1% Triton X-100 in PBS. The coverslips
were mounted onto slides using ProLong Gold antifade reagent (Invitro-
gen). Images were acquired using a Leica (DMIRE2) confocal microscope
and analyzed using Leica software, version 2.61 (Leica Microsystems,
Heidelberg, Germany).
In another series of experiments, HeLa cells grown on coverslips were
incubated with 5-ethynyl-2=-deoxyuridine (EdU) solution at 37°C for 30
min as per the manufacturer’s instructions (Click-iT EdU imaging kits;
Invitrogen). After incubation, the cells were washed with PBS and fixed in
4% formaldehyde in PBS for 15 min at room temperature. Cells were then
washed again and permeabilized in 0.5% Triton X-100 in PBS for 20 min.
The permeabilization buffer was removed, and cells were washed twice
with 3% BSA in PBS. Coverslips were inverted onto a drop of reaction
cocktail and prepared as per the manufacturer’s instructions. The cells
were then washed with 3% BSA in PBS and blocked with Image-iT FX
signal enhancer for 30 min. The blocking solution was removed, and the
cells were washed once in PBS. Cells were incubated overnight with an-
ti-HA antibody in 3% BSA– 0.1% Triton X-100 in PBS. Coverslips were
washed three times for 10 min each with 0.1% Triton X-100 in PBS. The
cells were then incubated with Alexa Fluor 594 goat anti-mouse secondary
antibody (Invitrogen) diluted 1:1,000 in 0.1% Triton X-100 in PBS for 1 h.
Coverslips were DAPI stained and washed three times for 10 min each
with 0.1% Triton X-100 in PBS. The coverslips were mounted onto slides
using ProLong Gold antifade reagent (Invitrogen). Immunofluorescence
was detected with Chroma filter sets using an Olympus BX51 upright
microscope (100 plan-apo, oil, 1.4 numerical aperture [NA]) equipped
with a Sensicam QE (Cooke Corporation) digital charge-coupled device
(CCD) camera, motorized Z-axis controller (Prior), and Slidebook 4.0
software (Intelligent Imaging Innovations, Denver, CO). Optical sections
were collected at 0.5-mm intervals through the Z axis and processed using
no-neighbor deconvolution (Slidebook 4.0).
NMR chemical shift mapping to study the SLBP-Pin1 interaction.
NMR experiments were performed on an Inova 700-MHz spectrometer
with cryoprobe at 298 K. The 15N-Pin1 sample was buffer exchanged into
20 mM Tris acetate buffer, 50 mM NaCl (pH 6.0), 50 mM sodium sulfate,
1 mM DTT, and 90% H2O–10%
2H2O for NMR analysis. Phosphorylated
or unphosphorylated SLBP peptides were taken up in the NMR buffer and
were titrated into a 0.25 mM uniformly 15N-labeled Pin1 NMR sample up
to a 1:10 (Pin1/peptide) molar ratio. The spectral changes were monitored
by acquiring a series of sensitivity-enhanced (1H, 15N) heteronuclear sin-
gle quantum coherences (HSQCs) at peptide/Pin1 molar ratios of 0.1, 0.2,
0.3, 0.4, 0.5, 0.75, 1.0, 3.0, 5.0, and 10.0. 1H and 15N chemical shift assign-
ments of Pin1 were obtained from the BioMagResBank (BMRB) (ID
number 5305). Pin1 amide resonances were in either fast or intermediate
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exchange during the course of the NMR titration. No chemical shift per-
turbations occurred in the presence of the unphosphorylated peptide con-
trol. For resonances that exhibited fast-exchange behavior as a result of
added peptide, the total chemical shift perturbation (1H  15N) in hertz
was plotted against the ratio of peptide to Pin1. The fractional change in
chemical shift is related to the dissociation constant via the following
relationship:   [(b  f)/2][1  (pepo/Po)  1  Sqrt(1  pepo/Po 
Kd/Po)2  4pepo/Po], where  is the observed chemical shift, f is the
chemical shift of free Pin1, b is the chemical shift of fully bound Pin1,
pepo is the total peptide concentration, and Po is the total Pin1 concen-
tration. Values for dissociation constant (Kd) and the difference between
b and f were obtained by simultaneous fitting of the observed perturba-
tions for five residues to the above equation using a least-squares fit and
assuming a single binding site model. 1H and 15N chemical shift assign-
ments of Pin1 were obtained from the BMRB (ID number 5305).
RESULTS
Structural basis for the phosphorylated SLBP-Pin1 interac-
tion. We used an NMR-based chemical shift mapping assay to
investigate (i) whether Pin1 directly binds SLBP and (ii) if the
interaction is specific for phosphorylated SLBP. Since the interac-
tion of Pin1 with its substrates has been well characterized by
NMR (13, 19, 26–28, 43) and X-ray crystallography (45, 54, 66),
this approach allowed us to determine whether SLBP interacted
with Pin1 in a specific manner. In this assay, phosphorylated SLBP
at natural isotope abundance was titrated into a solution of “NMR
active” 15N-labeled Pin1, and the spectral and conformational
changes in Pin1 were monitored in the presence of increasing
amounts of unlabeled full-length phosphorylated SLBP (P-SLBP)
by collecting a series of (1H, 15N) HSQC spectra (Fig. 1A). Since
the SLBP is not isotopically labeled, it is invisible during the titra-
tion. As the backbone amide resonances of Pin1 are assigned, this
approach gives site-specific information about which amides are
sensitive to the presence of the SLBP ligand. The changes in the
NMR spectra can be mapped onto the structure of Pin1 to deter-
mine the binding interface (18, 19). Pin1 has a two-domain struc-
ture (45) consisting of an N-terminal WW domain that specifi-
cally recognizes phosphorylated Ser/Thr-Pro sequences and a
catalytic PPIase domain (Fig. 1). Two side chains on Pin1 make
specific contacts with the substrate in Pin1-substrate crystal struc-
FIG 1 Phosphorylated SLBP forms a specific complex with the prolyl isomerase Pin1 in vitro. (A) Chemical shift mapping of uniformly 15N-labeled Pin1 was
performed with the addition of increasing concentrations of unlabeled phosphorylated full-length SLBP. 15N-labeled Pin1 (0.25 mM) was titrated with increasing
molar ratios of phosphorylated SLBP (phospho-SLBP) as indicated. The free (1H, 15N) HSQC Pin1 spectrum is shown in blue, and the (1H, 15N) HSQC Pin1
spectrum with SLBP is shown in red. All spectra were apodized identically and are plotted at the same contour level. At a substoichiometric ratio of 0.5:1 for
phospho-SLBP to Pin1, several Pin1 amides in the WW domain and the catalytic domain that are known to be part of ligand binding sites disappear from the
spectrum. These residues have been mapped onto the crystal structure of Pin1 (pdb code 1PIN in panel E). Only resonances from the disordered N terminus
remain visible (residue numbers are indicated) in the spectrum in the presence of an equivalent amount of phospho-SLBP. For panel B, a similar titration was
performed with baculovirus-expressed hSLBP RPD. The overlay of the free and RPD-bound Pin1 spectra is shown (C). No perturbations were observed in the
Pin1 spectrum when dephosphorylated SLBP (baculovirus expressed and treated with calf intestinal phosphatase) was titrated into the spectrum. (D) 31P NMR
spectra of phosphorylated human SLBP RPD are shown in the presence and absence of Pin1. Two resonances for a single phosphate on Thr171 are observed in
the 1D 31P spectrum due to cis-trans isomerization about the Thr-Pro bond. Addition of Pin1 changes the populations of the two conformers. (E) The chemical
shift perturbations from the NMR titration are depicted in red on the crystal structure of Pin1 (PDB code 1PIN).
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tures (45, 54): Trp34 in the WW domain of Pin1 stacks with the
substrate proline, while Arg17 interacts with the substrate phos-
phates. The complex was in intermediate exchange, and a number
of resonances broadened out of the Pin1 spectrum in the presence
of P-SLBP. The first residue to disappear from the spectrum at a
molar ratio of P-SLBP to Pin1 of 0.1:1 was Arg17 in the WW
domain of Pin1. An increase in the concentration of P-SLBP re-
sulted in disappearance of additional residues around Arg17 in the
WW domain. Consistent with previous analysis of Pin1-substrate
interactions, spectral perturbations were found to propagate from
the WW domain toward the PPIase domain in response to P-
SLBP. At a substoichiometric ratio of 0.5:1 for P-SLBP to Pin1,
several Pin1 amides in the WW domain and the catalytic domain
disappear from the spectrum (Glu12, Arg14, Ser18, Phe25, Asn26,
Ile29, Asn30, Gln33, Trp34, Ser58, His59, Leu61, Val62, Lys63,
Ser65, Ile78, Thr79, Thr81, Ser115, Gly120, Leu122, Gly128,
Gln129, Lys132, Ser138, Gly144, Ser147, Gly148, Thr152, Ser154,
Ile158, Ile159, and Arg161). These residues have been mapped
onto the crystal structure of Pin1 (Fig. 1E). At a stoichiometric
ratio of P-SLBP to Pin1, almost all Pin1 resonances broaden out of
the spectrum, with the exception of residues from the flexible N
terminus. No spectral changes are observed in the presence of
dephosphorylated SLBP (Fig. 1C). Therefore, the pattern of
chemical shift broadening observed indicates that Pin1 forms a
specific complex with full-length phosphorylated SLBP in vitro.
Using GST-Pin1 as bait, we were also able to pull out HA-SLBP
from HeLa cells that stably expressed HA-SLBP. HA-SLBP was
identified by Western blotting as well as MALDI-time of flight
(TOF) mass spectrometry to be hSLBP (data not shown).
We also compared the binding of different SLBP phosphopep-
tides comprising the SFTTP sequence in the SLBP N terminus and
the HPKTPNK sequence in the RNA binding domain (see Fig. S1
in the supplemental material) to 15N-labeled Pin1 using NMR
chemical shift mapping experiments as described above for full-
length phosphorylated SLBP. The phosphorylated peptides
bound Pin1 less tightly than the full-length phosphorylated pro-
tein, with both peptides binding Pin1 with a Kd of 1 M as was
estimated from NMR titrations. Under saturating conditions,
where the peptide/Pin1 molar ratio is 10:1, all peptides showed
very similar chemical shift perturbations of Pin1 amides. No per-
turbations in the Pin1 spectrum were observed for the unphos-
phorylated peptides.
Since the SLBP RPD exhibits proline isomerization about the
phosphor-Thr171-Pro172 bond, we also titrated baculovirus-ex-
pressed SLBP RPD into a solution of 15N-labeled Pin1 (Fig. 1B).
The baculovirus-expressed SLBP RPD was phosphorylated only
on one site (3), as we confirmed by electrospray ionization mass
spectrometry, and phosphorylation at this site appears to be stoi-
chiometric (3). We have no evidence for the presence of unphos-
phorylated SLBP RPD by either mass spectrometry or gel filtration
(65). Titration of an equimolar equivalent of SLBP RPD (1:1) into
a solution of 15N-labeled Pin1 resulted in broadening of cross-
peaks corresponding to residues in both the WW domain and the
prolyl isomerase domain of Pin1 in the (1H, 15N) HSQC spectrum
of Pin1, in a manner similar to that observed for the full-length
SLBP. Therefore, the isolated SLBP RPD forms a specific complex
with Pin1. To determine whether Pin1 also isomerized the SLBP
RPD about the Thr-Pro bond in the TPNK sequence, we collected
1D 31P NMR spectra (Fig. 1D) for the SLBP RPD at pH 8.0 in the
presence and absence of Pin1. We have recently shown (65) that
human and Drosophila SLBP RPDs are unstable and that the 1H
NMR spectra are not tractable to analysis by NMR. This prevents
application of traditional exchange spectroscopy NMR experi-
ments to study proline isomerization in the intact SLBP RPD. The
instability of the SLBP RPD is in large part due to proline isomer-
ization about the Thr171-Pro172 sequence. However, the 31P
NMR spectra of baculovirus-expressed SLBP RPD that is phos-
phorylated only at Thr171 in human SLBP show two resonances
for a single phosphate in the RBD at basic pH due to cis-trans
proline isomerization (Fig. 1D). Addition of Pin1 changes the rel-
ative populations of the cis and trans conformers in the 31P spectra,
confirming that Pin1 not only binds but also isomerizes SLBP in
the RPD (Fig. 1D).
Pin1 dissociates SLBP from the histone mRNA stem-loop.
Next, we investigated whether addition of Pin1 affected the stabil-
ity of the SLBP-histone mRNA complex by EMSA and fluores-
cence anisotropy assays (Fig. 2). We used full-length phosphory-
lated Drosophila SLBP (dSLBP), hSLBP, and hSLBP RBD
expressed in baculovirus for this analysis. dSLBP is phosphory-
lated predominantly in the RPD (7), and one additional phos-
phorylation site in the N terminus at T120 is present (29). In
contrast, baculovirus-expressed full-length hSLBP is a heteroge-
neous mixture of at least 23 different phosphorylation sites (Lam
and Thapar, unpublished), but it is stoichiometrically phosphor-
ylated at T171 in the RBD. The hSLBP RBD is phosphorylated
only on T171. A preformed complex of phosphorylated dSLBP
and stem-loop RNA labeled at the 5= end with 	-32P was treated
with Pin1 in the presence and absence of cold competitor RNA,
and EMSAs were performed (Fig. 2A). When the 5=-end-labeled
RNA probe is mixed with SLBP and run on a native gel, the pro-
tein-RNA complex mobility is retarded, as is expected for a stable
complex (Fig. 2A to C). The cold RNA competitor was added 20
min after the 5=-end-labeled stem-loop RNA was incubated with
SLBP. Addition of a 10-fold excess of cold competitor RNA to the
preformed complex does not result in dissociation of the complex
as shown in Fig. 2B. When increasing amounts of Pin1 are added
to the reaction in the absence of cold RNA, a slight retardation in
the mobility is observed (Fig. 2A, left), indicating that Pin1 may
form a ternary complex with the SLBP and histone mRNA. How-
ever, addition of a 10-fold excess of cold competitor RNA in the
presence of Pin1 results in complex dissociation and partial ex-
change of the labeled and unlabeled RNA. The radioactive free
probe is released and runs at the bottom of the gel (Fig. 2A, mid-
dle). Increasing the concentration of Pin1 results in a correspond-
ing increase in the release of the free probe, indicating that the
effect is directly due to Pin1 activity (Fig. 2A, middle). Pin1 is also
known to interact with PP2A in vivo to dephosphorylate Pin1
targets. Interestingly, when PP2A is added to the preformed com-
plex of SLBP and 5=-end-labeled RNA complex (in the absence of
Pin1), the complex is highly stable and does not dissociate even
when a 10-fold excess of cold RNA is present in the reaction, as
probed by EMSA (Fig. 2B, lanes 1 and 2). However, when catalytic
amounts of PP2A are added along with Pin1 and an excess of cold
competitor RNA, free 32P-labeled stem-loop RNA is observed at
the bottom of the gel (Fig. 2A, right). As previously shown, the
unphosphorylated SLBP has a high off-rate, allowing exchange of
the labeled and unlabeled RNA (65). Increasing the concentration
of Pin1 facilitates dissociation in the presence of PP2A. Therefore,
a Pin1-mediated conformational change is required to facilitate
Regulation of Histone mRNA Turnover by Pin1
November 2012 Volume 32 Number 21 mcb.asm.org 4311
FIG 2 The SLBP-histone mRNA complex dissociates in the presence of Pin1 and PP2A. (A) Dissociation of the dSLBP-RNA complex monitored by EMSA.
32P-labeled histone stem-loop RNA was incubated with the baculovirus-expressed full-length (FL) dSLBP on ice either with or without the various enzymes as
indicated. (Left) Addition of Pin1 alone does not dissociate the preformed dSLBP-RNA complex. SLBP was at 40 nmol in all lanes in a total reaction volume of
10 l, whereas the Pin1 concentrations were 50 nmol (lane 1), 100 nmol (lane 2), 200 nmol (lane 3), and 400 nmol (lane 4). No Pin1 was added to the “0” lane.
The 32P-labeled RNA was at 1 pmol in all lanes. (Middle) Addition of increasing concentration of Pin1 and a 10-fold excess of SL28 RNA (relative to the
32P-labeled RNA) results in accumulation of free [32P]ATP at the bottom of the gel. SLBP was at 40 nmol in all lanes in a total reaction volume of 10 l, whereas
the Pin1 concentrations were 50 nmol (lane 1), 100 nmol (lane 2), 200 nmol (lane 3), 400 nmol (lane 4), and 800 nmol (lane 5). No Pin1 was added to the “0”
lane. (Right) The 32P-labeled histone stem-loop probe is released more efficiently when the complex is incubated with increasing concentrations of Pin1 and a
fixed concentration (0.3 nmol) of PP2A. The concentrations of SLBP, RNA, and Pin1 are the same as those described for the middle panel. (B) The control panel
shows that addition of neither cold RNA alone nor phosphatase alone results in dissociation. Dissociation is observed only when Pin1 is present in the presence
of excess competitor RNA. (C) Binding of Pin1 to the full-length baculovirus-expressed phosphorylated human SLBP-RNA complex was monitored by EMSA
in the presence and absence of the Pin1 inhibitor PiB, but without excess competitor RNA. No effect of Pin1 was apparent on the preformed complex in either
reaction. (D) Binding of Pin1 of the baculovirus-expressed phosphorylated human SLBP-RPD RNA complex was monitored by EMSA in the presence and
absence of the Pin1 inhibitor PiB and PP2A. Addition of Pin1 and PP2A to the human SLBP RPD-RNA complex (in the absence of competitor RNA) results in
the complex running diffuse through the gel, indicating that some dissociation occurs even in the absence of cold RNA. The SLBP RBD was at 10 nmol, the
32P-labeled RNA was at 0.5 pmol, Pin1 was at 20 nmol (lane 1) and 40 nmol (lane 2), and PP2A was at 0.3 nmol. (D) Fluorescence anisotropy for the association
of 3= fluorescein-labeled histone stem-loop RNA with phosphorylated full-length human SLBP, Pin1, PP2A, and a 10-fold excess of unlabeled competitor RNA
is shown. Addition of Pin1 to the SL28-SLBP binary complex results in an increase in fluorescence anisotropy. Addition of PP2A results in a small decrease in the
anisotropy, and a complete decrease in anisotropy to baseline is observed when unlabeled SL28 RNA is added to the (SL28 plus hSLBP-Pin1 plus PP2A) mixture.
(E) Binding isotherm for interaction of human SLBP with 3= fluorescein-labeled histone stem-loop RNA (1), addition of Pin1 to the SLBP-RNA complex in the
absence of competitor RNA (2), and addition of Pin1 and PP2A to the SLBP-RNA complex in the presence of competitor RNA (3) is shown. In panel F, the
individual isotherms for these reactions are shown. The apparent dissociation constants derived from the observed change in anisotropy are indicated. The
concentration of RNA for the fluorescence experiments was 50 nM, and 0.02 g of a 0.1 mg/ml solution of PP2A (corresponding to 0.4 enzyme units) was added
to the 500-l reaction mixture. (G) The concentrations of hSLBP and Pin1 are indicated. All fluorescence experiments were performed at 25°C in PBS buffer (pH
7.4), and each data point was measured in triplicate.
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phosphatase activity. No dissociation is evident in the absence of
cold competitor RNA or with PP2A alone (Fig. 2B).
To confirm the results of the EMSAs, we used fluorescence
anisotropy to characterize the SLBP-RNA binding reactions in the
presence of Pin1 and/or PP2A. The histone mRNA stem-loop was
labeled at either the 5= or 3= end with fluorescein (FAM), and the
binding of human SLBP to labeled RNA was characterized in the
presence and absence of Pin1 and the phosphatases by fluores-
cence anisotropy. Introduction of 5= FAM was detrimental to
complex formation (data not shown). This is likely due to steric
effects, since the 5= flanking region is important for SLBP-RNA
contacts (59). Therefore, all binding experiments were performed
with histone mRNA stem-loop with 3=-end FAM. Addition of
phosphorylated full-length baculovirus-expressed SLBP to his-
tone stem-loop labeled with fluorescein at the 3= end results in an
increase in anisotropy due to formation of the SLBP-RNA com-
plex (Fig. 2E). When fit to a 1:1 binding isotherm, the results yield
a Kd of 67.6  1.5 nM (Fig. 2E to G). When Pin1 is titrated into this
complex (in the absence of unlabeled competitor RNA), a steady
increase in fluorescence anisotropy is observed, as indicated by the
EMSA indicating formation of a ternary (Pin1-SLBP-RNA) com-
plex. The apparent Kd for Pin1 interaction with the SLBP-RNA
complex was determined to be 166.2  5.9 nM (Fig. 2E to G).
When PP2A is added to the Pin1-SLBP-RNA complex, a small but
significant decrease in fluorescence anisotropy is observed (Fig.
2E), indicating that PP2A promotes dissociation of the com-
plex, but in the absence of cold competitor RNA there is prob-
ably rebinding of SLBP to the labeled RNA. However, addition
of a 10-fold excess of unlabeled stem-loop RNA to this mixture
containing Pin1 and PP2A competes off SLBP from the fluo-
rescein-labeled RNA, and the anisotropy value returns to that
of the free fluorescein-labeled RNA at the beginning of the
titration (Fig. 2E to G). Thus, the fluorescence anisotropy and
the mobility shift assays suggest that Pin1 and a phosphatase
such as PP2A can act to increase the off-rate of SLBP from the
stem-loop at the 3= end of histone mRNA, allowing exchange of
labeled and unlabeled RNA in the complex. The results are
consistent with our published studies (3, 65) showing that
SLBP that is dephosphorylated at Thr171 has a higher off-rate
for the histone mRNA stem-loop.
The requirement for both Pin1 and PP2A to dissociate a highly
specific and stable SLBP-RNA complex is an unexpected result but
of great potential significance. It suggests that the enzymes might
work together in the cell to dissociate SLBP from the histone
mRNA or pre-mRNA. Since the catalytic synergy between Pin1
and PP2A has also previously been reported for the Pin1 sub-
strates Cdc25 (68) and Raf-1 (8), a likely candidate for the phos-
phatase that dephosphorylates SLBP in vivo is PP2A.
Pin1 regulates SLBP protein stability and its ubiquitination.
In order to determine the effects of Pin1 isomerase activity on
SLBP levels, we knocked down Pin1 in HeLa cells (Fig. 3A) and
HEK293 cells (Fig. 3B) using either a pool of four different siRNAs
or a single siRNA. HeLa cells were transfected with either S2 or
control (C2) siRNA against Pin1. These S2 siRNAs were specific
for Pin1, since similar biological effects were observed irrespective
of the siRNA used and independent of the cell line, suggesting that
off-target effects were minimal. Pin1 siRNA knockdown had no
effect on the protein levels of actin and several other proteins
tested, including factors necessary for 3=-end cleavage and poly-
adenylation, such as CPSF73, CPSF100, and symplekin, that are
required for processing of both poly(A) and histone mRNAs
(Fig. 3A; see also Fig. S2 in the supplemental material). These
factors were all unaffected by Pin1 knockdown with the exception
of CPSF160, which increased after Pin1 knockdown. CPSF160 is
the RNA binding protein component of the cleavage and poly-
adenylation complex (CPSF) that may participate in process-
ing both polyadenylated and histone mRNAs (22). Pin1 pro-
tein levels did not change appreciably in the presence of the C2
control during 72 h (Fig. 3A). Intriguingly, we found time-
dependent accumulation of SLBP in HeLa cells as well as
HEK293 cells that were treated with Pin1 siRNA, but not in
those treated with the C2 siRNA. The increased protein levels
of SLBP after siRNA knockdown could be rescued within 24 h
after transfection of exogenous Flag-tagged Pin1 (Fig. 3D). In
addition to SLBP, we tested the levels of other polyadenylation
factors such as CPSF73, CPSF100, and symplekin that are re-
quired for processing of both poly(A) and histone
mRNAs. These factors were all unaffected by Pin1 knockdown,
with the exception of CPSF160, which increased after Pin1
knockdown (see Fig. S2 in the supplemental material).
Pin1 has been shown to be a mitotic regulator (37), and Pin1
knockdown in mouse embryonic fibroblasts (MEFs) (63) has pre-
viously been reported to show increased accumulation of cells in
G1 phase and decrease in G2/M cells due to slower cell cycle pro-
gression, inability of cells to synthesize DNA, and deregulation of
cyclin E, a target of Pin1. To see whether we observed a similar
effect in HeLa cells, we performed fluorescence-activated cell sort-
ing (FACS) on our S2- and C2-treated samples (Fig. 3E). Similar
to the previous study, we observed an accumulation of cells in G1
and a decrease in S-phase and G2/M-phase cells, suggesting that an
75% knockdown of Pin1 slowed progression to S phase. FACS
analysis on HeLa cells (Fig. 3E) showed that after Pin1 knockdown
in HeLa cells, there were significantly fewer cells in S phase (18%)
as well as G2 (6.5%) among Pin1 knockdown cells than among
those treated with the C2 siRNA (26.5% in S; 12% in G2), suggest-
ing that Pin1 knockdown slowed cell cycle progression into S
phase. Since SLBP is expressed only during S phase (58), the
increase in accumulation of SLBP that is observed in Pin1 siRNA-
treated cells is likely underestimated, as there are 30% fewer cells
in S phase among these cells.
To confirm that the observed increase in SLBP levels could be
attributed to Pin1 activity, we analyzed SLBP levels after treating
HEK293 cells with the Pin1 inhibitor PiB (Fig. 3C). PiB is highly
selective toward Pin1 and inhibits Pin1 isomerase activity (53). A
similar increase in SLBP levels was observed after chemical inhi-
bition of Pin1 (Fig. 3C and F), indicating that Pin1 regulated SLBP
levels. The mRNA levels of SLBP were also probed in PiB-treated
cells by reverse transcription-PCR (Fig. 3C) and they remained
identical to those of the control. The effect of PiB on SLBP stability
was measured in HEK293 cells in the presence and absence of PiB
by treating cells with cycloheximide and monitoring the decrease
in SLBP levels over time (Fig. 3F). There was a clear difference in
the rate of decay of SLBP particularly during the first 4 h after
treatment with cycloheximide, indicating that Pin1 increased
SLBP stability.
To determine whether Pin1 interacted directly with SLBP in
vivo, HeLa cell lysates were treated with an anti-Pin1 antibody and
the immunoprecipitates were analyzed for SLBP and Pin1. We
also did the reciprocal experiment using SLBP antibody and ob-
served very efficient coimmunoprecipitation of the two proteins
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(Fig. 3G). This interaction is not RNA dependent, since treatment
of the lysates with RNase prior to immunoprecipitation did not
abolish the interaction (Fig. 3G). Therefore, the two proteins in-
teract directly in vivo.
There are six different Ser-Pro/Thr-Pro sites present in human
SLBP, and previous phosphoproteomic analysis has shown that
each of these sites is phosphorylated in vivo (12). Of these, two
sites have been well characterized: one corresponding to the
SFT60T61P sequence in the SLBP N terminus (67) and the second
corresponding to a conserved T171PNK sequence in the SLBP
RNA binding domain that is important for RNA binding (29). To
determine which phospho-Thr-Pro site was being targeted by
Pin1 in vivo, we transiently transfected Flag-tagged wild-type
SLBP into HEK293 cells and after 24 h either mock treated the cells
with DMSO or treated them with the Pin1 inhibitor PiB. The
Flag-tagged SLBP was purified using anti-Flag resin as described
in Materials and Methods, and the highly purified protein was
analyzed by mass spectrometry (Fig. 4). Several unique phospho-
peptides were identified in human SLBP, and the data confirmed
that human SLBP is phosphorylated at three additional Ser-Pro
sites in the N terminus, namely, Ser7, Ser20, and Ser23 (Fig. 4).
When the relative enrichment of phosphopeptides was quantified
in PiB-treated cells relative to the control untreated cells by mass
spectrometry, we observed 2- to 3-fold phosphate enrichment at
Ser7, Ser20, Ser23, Ser221, Ser222, and Thr226 in addition to
Thr171. The Thr171 site showed the largest change in relative
enrichment. We did not observe phosphopeptides corresponding
to Thr60 or Thr61 in the SFTTP sequence. These are likely of low
FIG 3 Pin1 inhibition increases SLBP levels. (A) HeLa cells were treated with either S2 or C2 siRNA for up to 72 h using a standard two-hit method. The levels
of Pin1, SLBP, and actin were probed by Western blotting (WB) as noted. (B) HEK293 cells were treated with either S2 or C2 Pin1 siRNA for 72 h, and the cells
were probed for Pin1 and SLBP. (C) Pin1 activity was inhibited by the addition of 20 M PiB inhibitor for 16 h, whereas control cells were mock treated with
DMSO. The protein levels of SLBP, Pin1, and actin were determined by Western blotting. The SLBP mRNA levels were also quantified in the control and
PiB-treated cells by RT-PCR. (D) The effect of the Pin1 siRNA on SLBP levels could be rescued by the transfection of exogenous WT Flag-tagged Pin1 for 24 h
into HEK293 cells after Pin1 was knocked down by 50 nM siRNA for 48 h. (E) Pin1 knockdown results in increased accumulation of cells in G1 and reduced
accumulation in S and G2 phases. Cell cycle profiles of HeLa cells treated with either 25 nM Pin1 siRNA (S2) or 25 nM control RNA (C2) for 72 h were
pulse-labeled with propidium iodide; the DNA content was analyzed by flow cytometry, and the cell cycle distribution was determined using the ModFit software.
(F) The Pin1 inhibitor PiB affects the stability of SLBP. The levels of SLBP were analyzed at different time points after treatment with cycloheximide in the
presence and absence of the Pin1 inhibitor PiB. The protein levels were quantified using ImageQuant software. (G) Pin1 coimmunoprecipitates with HA-SLBP.
HeLa cell lysates were prepared from a cell line that stably expressed HA-SLBP. The lysates were treated with Pin1 antibody as described in Materials and Methods.
Anti-Myc antibody was used as the control. The immunoprecipitates were run on SDS-PAGE and probed for Pin1 and HA-SLBP. A total of 5% of the input was
run in the first lane as a control. No SLBP is observed in the anti-Myc control lane (lane 2).
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abundance, particularly in an asynchronous population of
HEK293 cells, since T61 is phosphorylated by cyclin A/Cdk1,
which is present at the end of S phase but not at other times during
the cell cycle. The mass spectrometry data suggested that there are
several phosphorylation sites that are targeted by Pin1 in human
SLBP besides Thr171. We next transiently transfected the Flag-
tagged SLBP WT and mutant proteins and pulled down the SLBPs
using an anti-Flag resin. The resin was washed and then probed for
the presence of Pin1 by Western blotting (Fig. 5E). We found that
no single point mutant completely abolished interaction with
Pin1; however, the SLBP Thr60A/Thr61A/Thr171A triple mutant
showed a significant reduction in binding to Pin1. Therefore, in
addition to Thr171 in the SLBP RPD, there are additional Ser/Thr-
Pro sites in the SLBP N-terminal domain that are targeted by Pin1.
Since there are two binding sites on Pin1 for phosphopeptides,
one in the WW domain and the second in the prolyl isomerase
FIG 4 Identification of SLBP phosphorylation sites upregulated in response to PiB inhibitor by mass spectrometry. Several phosphorylation sites in human SLBP
were mapped using high-resolution tandem mass spectrometry. The MS-MS spectrum in panel A illustrates a typical high-energy C-trap dissociation (HCD)
fragmentation pattern obtained on an LTQ Orbitrap Elite MS instrument for an SLBP phosphorylated peptide (in this case, it is peptide 1 in panel D showing
phosphorylation of S20 and S23). The bar graph in panel B compares the normalized abundance (based on a global scaling factor of all observable peptides in the
LCMS experimental run) of SLBP phosphorylated peptides obtained from HEK293 cells treated without (blue) or with (red) 20 M PiB inhibitor. Mass spectra
were compared using Nonlinear Dynamics’ Progenesis LCMS software (version 3.1.4003.30577) as described in Materials and Methods. The three inset
chromatographs show the elution profiles of a phosphopeptide that was upregulated in the presence of PiB (top), a downregulated phosphopeptide (middle), and
a phosphopeptide whose abundance was comparable (lower) in SLBP isolated in the presence or absence of PiB. The zoom in the inset illustrates additional
phosphorylated SLPB peptides of lower abundance that show significant upregulation (labeled 1, 2, 3, 4, and 5) in the presence of PiB. (Note that the
chromatographs corresponding to SLBP  PiB are offset.) (C) The domain organization of human SLBP is shown. TAD, translation activation domain; RPD,
RNA binding and processing domain. Ser/Thr phosphorylation sites that show at least a 2-fold increase in abundance in the presence of PiB are shown. In panel
D, the phosphorylated peptides identified are shown along with the corresponding fold enrichment in the presence of PiB. The numbering of the peptides
corresponds to that depicted in panel B.
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domain, the data suggest that a bipartite mode of recognition is
likely. During S phase, Pin1 may interact with Ser20/Ser23 as well
as T171, as the mass spectrometry data suggest.
To determine whether Pin1 affected SLBP ubiquitination by
the ubiquitin-proteasome system, we treated HEK293 cells with
the proteasome inhibitor ALLN in the presence and absence of PiB
(Fig. 5A). Treatment with either ALLN, PiB, or both increased
SLBP levels. To determine whether Pin1 played a role in SLBP
polyubiquitination, we knocked down Pin1 using siRNA and
cotransfected Flag-SLBP WT and His-tagged ubiquitin into these
cells (Fig. 5B). We found that knockdown of Pin1 by siRNA also
resulted in significant accumulation of polyubiquitinated SLBP.
Therefore, there is an increase in the levels of free SLBP as well as
polyubiquitinated SLBP in the cell when Pin1 is inhibited. The
FIG 5 Pin1 regulates SLBP ubiquitination. (A) SLBP is degraded by the proteasome and Pin1. HEK293 cells were either treated with 20 M PiB for 16 h or mock
treated with DMSO to inhibit Pin1 as indicated, and/or treated with the proteasome inhibitor ALLN for 4 h before harvest. The SLBP and actin levels were probed
in these cells by Western blotting. For panel B, HEK293 cells were treated with either control or Pin1 siRNA for 48 h, after which they were transiently
cotransfected with (His)6-tagged ubiquitin and Flag-tagged WT SLBP followed by treatment with ALLN. The lysates were purified on a nickel column as
described in Materials and Methods to capture ubiquitinated proteins and then probed for ubiquitinated SLBP using an anti-SLBP antibody. (C) Flag-tagged
SLBP WT or T171A or T60A/T61A mutants were immunoprecipitated (IP) from HEK293 cells expressing these proteins along with HA-tagged ubiquitin in the
presence or absence of PiB inhibitor. Anti-Myc antibody was used as a control. The ubiquitinated SLBP was probed using the anti-HA antibody. (D) Pin1 siRNA
increases accumulation of ubiquitinated SLBP in all SLBP mutants except S20A/S23A SLBP. HEK293 cells were treated with control or Pin1 siRNA, followed by
cotransfection of Flag-tagged WT or mutant SLBP forms with (His)6-tagged ubiquitin. The ubiquitinated proteins were purified over a nickel column as
described in Materials and Methods. The lysates were probed for the presence of SLBP using the anti-SLBP antibody. A significant accumulation of ubiquitinated
SLBP was observed when Pin1 was knocked down by siRNA, and no ubiquitination of SLBP was observed for the S20A/S23A mutant in either control or Pin1
siRNA-treated cells. (E) Flag-tagged SLBP WT and mutants were transiently transfected into HEK293 cells. The SLBP was immunoprecipitated using the Flag
antibody and probed for Flag-tagged SLBP and Pin1. Only the T171A/T60A/T61A triple mutant significantly abrogated the SLBP-Pin1 interaction, indicating
that multisite phosphorylation at these sites is required for interaction with Pin1.
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same effect was observed when Pin1 was chemically inhibited with
PiB in HEK293 cells that were cotransfected with HA-Ub and
Flag-SLBP (Fig. 5C). When we performed ubiquitination assays
using the SLBP mutants (Fig. 5D), we found that mutation of
Ser20 and Ser23 to alanines in the SLBP N terminus completely
blocked SLBP ubiquitination. This effect was observed in cells
treated with control siRNA as well as Pin1 siRNA. It was also
observed in the context of the S20A/S23A/T171A triple mutant.
This result is intriguing, as we see significant enrichment of these
phosphorylation sites by mass spectrometry when Pin1 is inhib-
ited. These results suggest that Pin1 plays two distinct roles in
regulating SLBP. First, it interacts with phosphorylated Thr171 to
facilitate dissociation of the SLBP-RNA complex, and second, it
interacts with Ser/Thr-Pro sequences in the N terminus that in-
clude Ser20, Ser23, and possibly Thr60 and Thr61 to regulate
SLBP polyubiquitination. Since we observed SLBP polyubiquiti-
nation in the Thr60/Thr61 double mutant, our data suggest that
the Ser20/Ser23 site in the N terminus is the major phosphode-
gron for SLBP ubiquitination in asynchronous cells.
Pin1 knockdown promotes nuclear localization of SLBP.
Human SLBP is a cell cycle-regulated protein (58), accumulating
during the S phase of the cell cycle when histones are synthesized
and DNA synthesis occurs. SLBP is found in both the nucleus and
the cytoplasm during S phase (9). In the nucleus, SLBP is required
for histone pre-mRNA processing (6), whereas in the cytoplasm,
SLBP is important for histone protein synthesis (47) and is asso-
ciated with histone mRNA. Inhibition of DNA replication results
in a degradation of histone mRNA and a relocalization of SLBP to
the nucleus (57).
To determine the role of T171 phosphorylation of SLBP in
mammalian cells, we transiently transfected HA-tagged wild-type
and T171A, T171D, and T171E human SLBP mutants into HeLa
cells and determined the localization of the HA-tagged SLBP in
asynchronously growing HeLa cells using a monoclonal anti-HA
antibody. To distinguish between S-phase cells and cells in the
G1/G2 phases of the cell cycle, we pulse-labeled the transfected
HeLa cells with the nucleoside analog 5-ethynyl-2=-deoxyuridine
(EdU) (as described in Materials and Methods) and immunola-
beled the sites of EdU incorporation using the Click-iT 488 EdU
kit (see Materials and Methods). Since EdU is incorporated only
into single-stranded DNA, only S-phase cells are labeled (5). In
addition, the spatial distribution of EdU-containing fluorescent
foci in the cell nucleus allows one to distinguish between early-S-,
mid-S-, and late-S-phase cells (A. Fritz and R. Berezney, unpub-
lished results), as previously determined following bromodeoxy-
uridine incorporation (5, 42). The levels of the transiently trans-
fected HA-SLBP wild type and mutants were similar to that of
endogenous SLBP by Western blotting. Wild-type HA-SLBP was
cell cycle regulated in a manner similar to that reported in previ-
ous studies (9, 58) (Fig. 6A). HA-SLBP was predominantly nu-
clear throughout the cell cycle and was only present in S-phase
cells (58). In mid-S-to late-S-phase cells, some cytoplasmic stain-
ing was also observed, consistent with reports that SLBP partici-
pates in histone mRNA translation in the cytoplasm (Fig. 6A; see
also Fig. S3 in the supplemental material) (47, 57). In contrast to
findings for the wild-type SLBP, a significant number of non-S-
phase cells showed high levels of T171A mutant SLBP (see Fig. S3
in the supplemental material). The T171A mutant was signifi-
cantly more cytoplasmic in these cells (Fig. 6A; also see Fig. S3),
suggesting that phosphorylation of SLBP at T171 is required for its
efficient import into the nucleus. In contrast, the T171D and
T171E SLBP mutants were almost exclusively nuclear throughout
the cell cycle and were also present in cells that were not in S phase
(did not stain for EdU), suggesting that T171 dephosphorylation
is essential for the regulated degradation of SLBP in the nucleus at
the end of S phase (Fig. 6A).
To determine the effect of Pin1 on SLBP localization, we ex-
amined the localization of endogenous SLBP and Pin1 in control
and Pin1 siRNA-treated HeLa cells (Fig. 6B). Pin1 was found to be
predominantly nuclear in HeLa cells and the fluorescence inten-
sity was dramatically attenuated in the siRNA-treated cells, as ex-
pected. Since Pin1 is known to localize in nuclear speckles (44), we
also probed for SC-35, a splicing factor that accumulates in speck-
les. Pin1 knockdown had no effect on speckle formation based on
the SC-35 staining, indicating that the nuclear structure remains
relatively unchanged in these cells. A significantly higher fluores-
cent signal was observed for endogenous SLBP in the nucleus that
persisted throughout the cell cycle, similar to the localization of
the T171D and T171E mutants (Fig. 6B). We also probed for the
HA tag in HeLa cells that were stably transfected with HA-SLBP
and obtained results identical to those with the endogenous pro-
tein (Fig. 6C). Intriguingly, CPSF160, which is also stabilized in
response to the Pin1 siRNA, accumulates in the nucleolus in these
cells (Fig. 6B).
The high-resolution microscopy images provided qualitative
evidence that a Pin1 knockdown resulted in increased nuclear
accumulation of both endogenous SLBP and HA-SLBP in HeLa
cells that stably express HA-SLBP. A drawback of microscopy is
that the interpretation of increased nuclear accumulation is based
solely on visual analysis of 50 to 100 cells. To obtain statistically
significant data, we used ImageStream (IS) flow cytometry, which
combines the strength of flow cytometry with microscopy (39). In
this analysis, cells are stained for SLBP-FITC (to stain for the en-
dogenous SLBP in untransfected cells) as well as DRAQ5, a nucle-
us-specific stain. The FITC and DRAQ5 fluorescence is simulta-
neously imaged, and at least 5,000 events are captured for control
and treated cells. A similarity score (SS), which is the log-trans-
formed Pearson’s correlation coefficient between the pixel values
of the FITC and DRAQ5 image pairs, reflects the degree of nuclear
accumulation of SLBP. Looking at the distribution histograms for
the similarity score (Fig. 6D), a higher similarity score indicates
that there is strong correlation between the signal intensity distri-
bution of SLBP and DRAQ5 in the nucleus associated with nuclear
localization of SLBP, and conversely, a shift to the left means a
weaker correlation, associated with a more cytoplasmic distribu-
tion of SLBP. The mean similarity score for the control population
of HeLa cells was 0.26, and that for Pin1 siRNA-treated HeLa
cells was 0.8. An increase in SLBP fluorescence was also observed
in the knockdown (mean fluorescence intensity was 65,000 for the
Pin1 siRNA-treated cells versus 58,000 for the control). Therefore,
the IS data indicate that there is an increase in SLBP levels in Pin1
siRNA-treated cells, and the excess SLBP is compartmentalized in
the nucleus. Taken together, these studies demonstrate that
downregulating Pin1 results in increased accumulation of SLBP in
the nucleus, mimicking the localization of the phosphomimetic
T171E and T171D SLBP mutants.
Downregulation of Pin1 activity increases histone mRNA
abundance and stability. To understand the effects of Pin1 on
regulation of histone mRNA abundance, we knocked down Pin1
using RNA interference (RNAi) in HeLa cells and HEK293 cells
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and analyzed the total RNA by qRT-PCR. Intriguingly, all five core
replication-dependent histone mRNAs (H1, H2A, H2B, H3, and
H4) showed increased mRNA abundance in Pin1 RNAi-treated
cells (Fig. 7A). The observed increase in abundance is between 1.3-
and 3.0-fold (Fig. 7A) for H2A, H2B, H3, and H4. Since histone
mRNAs are expressed only during S phase, and Pin1 RNAi knock-
down cells show fewer S-phase cells (Fig. 3E), this represents ap-
proximately a 1.7- to 4.0-fold change in histone mRNA abun-
dance overall. This apparently modest change in steady-state
mRNA levels is biologically significant, since previous studies re-
port 2- or 3-fold changes in histone mRNA steady-state levels as a
result of alterations in regulated decay pathways that affect histone
mRNA turnover (20, 48). A similar increase in histone mRNA
abundance was observed when HEK293 cells were treated with the
PiB inhibitor (Fig. 7B). The increase in histone mRNA levels was
restored to control levels when Pin1 was overexpressed in siRNA-
treated cells (Fig. 7C). Surprisingly, overexpression of the Pin1
W34A mutant, which is considered to be binding defective toward
Pin1 substrates, also restored histone mRNA levels (Fig. 7C), in-
dicating either that overexpression of this mutant is sufficient to
compensate for the decreased binding or that W34 does not play a
critical role in interaction with SLBP. In addition, a 2-fold increase
in histone mRNA levels was observed when SLBP WT or SLBP
T171E was transfected into the control and siRNA-treated cells.
However, histone mRNA levels were reduced by 40 to 50% in the
context of T171A SLBP (Fig. 7C). These experiments demonstrate
that the observed effects on histone mRNA levels are due to the
prolyl isomerase activity of Pin1 on the T171-Pro172 site of hu-
man SLBP.
To determine whether the observed increase in histone mRNA
abundance was due to decreased rate of decay of the histone
mRNA, we synchronized HEK293 cells by double-thymidine
block and measured the histone mRNA levels cells after addition
of hydroxyurea (HU) in the presence and absence of PiB (Fig. 7D).
Addition of HU triggers histone mRNA decay due to inhibition of
DNA synthesis. Cells were harvested every 15 min for 1.5 h after
addition of HU, and the mRNA levels of histone H1, H4,
H2A,H2B, and H3 were quantified by RT-PCR. The data suggest
that the increased abundance of the histone mRNAs due to inhi-
bition of Pin1 with PiB was due to a decreased rate of decay (Fig.
7D). Therefore, Pin1 affects histone mRNA stability.
Together, these data suggest that Pin1 is involved at multiple
steps in SLBP function and hence in the regulation of histone
mRNAs in the cell.
DISCUSSION
In this study, we have shown that SLBP is a substrate for Pin1 in
vivo and that histone mRNA abundance and SLBP levels are al-
FIG 6 Localization of SLBP T171 mutants and SLBP in Pin1 siRNA-treated cells. (A) The distribution of SLBP wild type and T171A and T171E mutants in HeLa
cells was visualized in 0.5-m optical sections following deconvolution. The SLBP is shown in red, the DAPI in blue, and the EdU in green. The first image in panel
A shows a cell in early-mid-S phase with WT SLBP present predominantly in the nucleus, but some SLBP is also in the cytoplasm. The second panel shows two
cells with T171A SLBP staining. One cell is in early S phase and shows nuclear and some cytoplasmic staining. The second cell is not in S phase and shows an
abundance of T171A SLBP in the cytoplasm. The third and fourth panels show the localization of T171E and T171D SLBPs, which is predominantly nuclear in
both S-phase and non-S-phase cells. The individual staining patterns are shown in Fig. S3 in the supplemental material. (B) Representative confocal microscopic
section images of control HeLa cells (left) and Pin1 siRNA-treated HeLa cells (right) that were stained with DAPI for nuclear imaging (in blue). Immunofluo-
rescence (IF) for Pin1, SLBP, CPSF160, and SC-35 is shown in red or green, and the merge panel is shown on the right of each data set. siRNA knockdown of Pin1
results in increased fluorescence intensity in the nucleus for SLBP, whereas CPSF160 partitions into the nucleoli. There is no change in speckle formation as
determined by the localization of SC-35 foci. (C) HeLa cells stably expressing HA-SLBP were probed to confirm the increase in nuclear signal observed in Pin1
siRNA-treated cells. HA-SLBP is shown in red, and DAPI is shown in blue. Representative confocal sections are displayed. (D) ImageStream analysis of control
and Pin1 siRNA-treated HeLa cells. Similarity score distributions as a measure of SLBP nuclear distribution for control HeLa cells (red) and Pin1 knockdown cells
(black) are shown. Representative composite images of SLBP (green) and DRAQ5 (red) corresponding to similarity scores are shown below.
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tered when Pin1 is inhibited. Pin1 has also been shown to regulate
the activity of AUF1 (10). There are a number of parallels in Pin1
regulation of histone mRNA metabolism via SLBP and the regu-
lation of the GM-CSF mRNA decay via AUF1 (10). In eosinophils,
all four isoforms of the ARE-binding protein AUF1 immunopre-
cipitate with Pin1 in cross-linking immunoprecipitation experi-
ments, and Pin1 regulates the association of AUF1 with the GM-
CSF mRNA in vivo (10, 50). AUF1 proteins were shown to
associate with GM-CSF mRNA only when Pin1 was inhibited with
juglone, whereas Pin1 activation by hyaluronic acid abolished
binding of AUF1 to the GM-CSF mRNA. Since AUF1 recruits the
exosome via direct interactions with PM-Scl-75, it was suggested
that removal of AUF1 would lead to stabilization of the mRNA.
Intriguingly, the decay of the GM-CSF mRNA is also linked to the
proteasome pathway (30, 31). Overexpression of deubiquinating
enzymes directly affects the half-life of the GM-CSF mRNA, al-
though the protein targets that mediate this effect have not been
identified.
We have shown using fluorescence and EMSA that the direct
interaction of phosphorylated SLBP with Pin1 can dissociate the
SLBP-histone mRNA complex in vitro, particularly when the re-
action is carried out in the presence of PP2A. Pin1 binds SLBP in
its RNA binding domain at a conserved TPNK sequence; phos-
phorylation of Drosophila SLBP (dSLBP) at this site (T230 in
FIG 7 Effect of Pin1 inhibition on histone mRNA levels. (A) HeLa cells were treated with 50 nM Pin1 siRNA for 72 h. The change in histone mRNA abundance
measured after Pin1 knockdown was validated by RT-PCR for five core histone genes, Pin1, and GAPDH. The average fold change determined from the CT values
using the comparative CT method is depicted with the standard errors derived from three independent data sets. (B) The effect of chemical inhibition of Pin1 by
the PiB inhibitor on histone gene abundance was determined in HEK293 cells by RT-PCR. The experiment was performed in triplicate. (C) HEK293 cells were
treated with either control siRNA (designated with a “-C” extension) or Pin1 siRNA (designated with an “-R” extension). Forty-eight hours after the second hit,
the cells either were left untransfected (UNTR) or were transfected with SLBP WT or the SLBP T171E or SLBP T171A mutant or Pin1 WT or the Pin1 W34A
mutant as indicated. The cells were harvested after 24 h, and the histone mRNA abundance for HIST1 H4 was quantified by RT-PCR as described in Materials
and Methods. (D) mRNA decay rates for four different histone mRNAs measured after the addition of hydroxyurea in the presence and absence of PiB in HEK293
cells. The experiments were done in triplicate. The mRNA was quantified for each time point using RT-PCR.
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dSLBP) is essential for viability of Drosophila embryos and for
histone pre-mRNA processing, and the mutant protein is not im-
ported into the nucleus (29). Transgenic flies that harbor a T-to-A
mutation at position 230 in dSLBP are unable to rescue the Slbp
null mutant phenotype, and the histone message is misprocessed
in vivo and is polyadenylated (29). We have shown that phosphor-
ylation of T171 in human SLBP (the equivalent of T230 in dSLBP)
also affects subcellular localization of human SLBP, although it
does not have the dramatic effect as seen with the Drosophila pro-
tein. More of the T171A SLBP mutant is in the cytoplasm than
wild-type SLBP, whereas the phosphomimetic mutants T171D
SLBP and T171E SLBP are predominantly nuclear. Knockdown of
Pin1 also results in increased accumulation of SLBP in the nu-
cleus, the likely site of SLBP degradation. In addition, we have
identified Ser20 and Ser23 in the sequence S20PPS23P as two new
phosphorylation sites that appear to be critical for SLBP polyubiq-
uitination. These sites may correspond to a phosphodegron that is
critical for polyubiquitination of SLBP during S phase and possi-
bly also at the end of S phase. Phosphorylation at these sites is
sensitive to Pin1 inhibition, and mutation of Ser20 and Ser23 to
alanines blocked SLBP polyubiquitination. In contrast, no inhibi-
tion of polyubiquitination was observed when the SFTTP se-
quence was mutated to alanines in our study.
Knockdown or inhibition of Pin1 also results in increased
abundance of histone mRNAs, at least partly due to stabilization
of histone mRNA. Taken together, our data suggest a model that is
summarized in Fig. 8. We propose that T171 phosphorylation is
important for high-affinity binding to the stem-loop necessary for
recruitment of SLBP to the site of histone pre-mRNA processing
in the nucleus. During S phase, SLBP remains phosphorylated at
T171 and accompanies the histone mRNP to the cytoplasm, where
it is important for translation of the histone mRNA. Dephosphor-
ylation of SLBP in its RNA binding domain by Pin1 and a phos-
phatase is likely to be necessary for removal of SLBP from the
histone 3= UTR at the end of S phase, resulting in decay of histone
mRNAs, and for subsequent proteasomal degradation of SLBP. It
is likely that inhibition of Pin1 decreases the rate of removal of
SLBP from the histone message, thereby stabilizing the mRNA.
The role of phosphorylation of S20 and S23 may be to regulate
proteasomal degradation of SLBP during S phase. The SLBP that is
released from the histone mRNP in the cytoplasm may reenter the
nucleus, where it may be recycled or degraded. At the end of S
phase, SLBP is phosphorylated by cyclin A/Cdk1, which either
triggers rapid degradation of SLBP by the proteasome (23) or
retains SLBP in the nucleus, thereby promoting its degradation.
Cdk1 has previously been shown to phosphorylate HuR, enhanc-
ing nuclear accumulation of HuR during G2 phase (21). The ki-
nases that phosphorylate SLBP at Ser20, Ser23, and Thr171 re-
main unknown. Additional studies are also required to identify
the E3 ligase(s) that interacts with SLBP and to determine the
pathway of SLBP degradation in the nucleus and how it may affect
other nuclear events such as histone pre-mRNA processing or
export of the histone messenger ribonucleoprotein (mRNP) to the
cytoplasm.
An interesting paradox in our study is that both histone mRNA
levels and SLBP levels were significantly increased, although we
had 30% fewer cells in S phase following downregulation or inhi-
bition of Pin1 activity. Since normally both histone mRNAs and
FIG 8 Model for the role of Pin1 in regulating histone mRNA decay. Our data suggest that T171 phosphorylation is required for efficient import of SLBP into the
nucleus during S phase. During S phase and at the end of S phase, Pin1 acts with a phosphatase such as PP2A to dephosphorylate SLBP, thereby dissociating SLBP from
the histone message in the cytoplasm. Pin1 may also regulate SLBP phosphorylation at the N terminus at Ser20 and Ser23, which we have identified as a phosphodegron
that controls SLBP polyubiquitination. At the end of S phase, SLBP is also phosphorylated at Thr60 and Thr61, which is reported to trigger SLBP degradation (67). The
histone mRNA is consequently degraded in the cytoplasm, whereas SLBP is degraded by the ubiquitin-proteasome pathway in the nucleus.
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SLBP are expressed at high levels only in S-phase cells, this sug-
gests either that there is more histone mRNA and SLBP per S-
phase cell or that histone mRNAs are no longer cell cycle regulated
and persist in the G1 and/or G2 phase of the cell cycle. SLBP is the
only factor whose levels are cell cycle regulated in a manner similar
to that of histone mRNA, raising the possibility that the levels of
SLBP and histone mRNA are coupled. However, current evidence
suggests otherwise. Histone mRNA levels respond to signals reg-
ulating DNA replication, whereas SLBP levels respond to cell cycle
signals. At the G1/S border, there is a large amount of SLBP, but
there is no histone mRNA (58). Similarly, SLBP degradation at the
end of S phase is not required for histone mRNA degradation. It
has been shown (67) that mutation of the SFTTP sequence that
results in a stable form of SLBP that persists into G2 phase has no
effect on the degradation of histone mRNA, which degrades at the
right time and with the same kinetics as is observed for endoge-
nous SLBP-expressing cells. Conversely, when histone mRNAs are
treated with inhibitors of DNA replication, the histone mRNA is
degraded, although SLBP is stable (33, 58).
How might we explain the increased levels of both histone
mRNA and SLBP in Pin1 knockdown cells? Our data suggest that
Pin1 acts at the rate-limiting step required for degradation of both
SLBP and histone mRNA, i.e., the dissociation of the SLBP from
the histone mRNA stem-loop. Regardless of the signals that regu-
late histone mRNA and SLBP levels in the nucleus and cytoplasm,
the histone mRNP must be remodeled at the end of S phase to
ensure efficient degradation of the histone mRNA and reentry of
the SLBP into the nucleus for ubiquitination and proteasomal
decay. Failure to dissociate the SLBP-histone mRNA complex
would affect both processes.
Pin1 has been reported to have both tumor-promoting and
inhibitory roles in cancer progression (32, 35, 52). Since a number
of Pin1 targets such as cyclin D, cyclin E, c-Myc, p53, p73, Raf
kinase, Cdc25, and Jun are cell cycle-regulated proteins whose
function is altered in tumorigenesis, Pin1 levels may promote un-
controlled growth of cancer cells via multiple signaling pathways.
Our studies add yet another mechanism by which loss of Pin1
function may impact uncontrolled proliferation in cancer. We
show that loss of Pin1 results in increased histone mRNA levels
that are likely to impact chromatin function outside S phase. In-
creased levels of core histone proteins outside S phase could com-
pete with the deposition of variant H2A and H3 histones, thereby
having profound consequences, altering chromatin function and
dynamics and having a more global effect on transcription, DNA
repair, and chromosome segregation.
In summary, we have shown that the half-lives of histone
mRNAs and the associated RNA binding protein SLBP are directly
influenced by Pin1 activity. Pin1 regulates SLBP stability, ubiq-
uitination, and localization and histone mRNA stability by play-
ing an essential role in remodeling the histone mRNP at the end of
S phase, when SLBP is required to dissociate from the histone
message for efficient mRNA decay. We propose that Pin1 may use
a similar mechanism to control the stability of a subset of eukary-
otic mRNAs that are inherently unstable by targeting their associ-
ated RNA binding proteins.
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